Bioneb has filed in the UK, USA, EU and WIPO in excess of 50 technology patents pending and has world wide exclusive rights on 28 patents approved . Bioneb has also filed many patent pending liquid formulations for over 130 FDA approved drugs including Humira®, Antibiotics, Insulin, Epinephrine, Imitrex®, Exubera, Anticholinergics, Anti-inflammatories, Hormones, Appetite suppressant, Dopamine agonist, Nicotine, Sildenafil, Sumatriptan, Vaccines, Diazepam, Antiemetics, Stimulants opioids, Suboxone®, Diphenhydramine, Morphine, Corticosteroids, Antiemetics, Buprenorphine Tadalafil. Patents have also been filed for bio-logic and bio-similar, insulin formulations, registered, viral formulations, natural medications, vitamin formulations, weight loss formulations and recreational hypertonic saline medical formulations.
Bioneb Limited, a corporation incorporated under the Laws of England and Wales located with its registered office at 78-80 St John Street, London, EC1M 4JA, United Kingdom.
Bioneb strives to be a leader in the pulmonary delivery of medical formulations.